Select your country

06.05.2020
Bausch + Lomb licenses exclusive rights from STADA and Xbrane
Bausch + Lomb licenses exclusive rights from STADA and Xbrane

To a biosimilar candidate for Lucentis (ranibizumab) in the United States and Canada

Read more

20.04.2020
Corona Survey
Corona Survey

Insights into how people in four major European countries are feeling about healthcare issues amid the COVID-19 crises.

Read more

09.04.2020
STADA responds to urgent need by making more medicines than ever
STADA responds to urgent need by making more medicines than ever

March 2020 saw the highest production output in STADA’s 125-year history as the COVID-19 crisis significantly raised demand for critical med…

Read more

05.03.2020
STADA closes acquisition of Walmark
STADA closes acquisition of Walmark

Creating a winning portfolio for Central Europe

Read more

04.03.2020
STADA takes clear lead in Russian consumer healthcare sector
STADA takes clear lead in Russian consumer healthcare sector

STADA has today closed a US$660 million transaction of a Russian brand portfolio from Takeda

Read more